The nucleotide hydrolysis is altered in blood serum of streptozotocin- induced diabetic rats

Archives of Physiology and Biochemistry

Volumn 116, Issue 2, 2010, Pages 79-87

  Rücker, Bárbara ^a   Vieira, Gustavo De A ^b   Bischoff, Lívia B ^b   Harthmann, Angela D'A ^b   Sarkis, João J F ^a   Wink, Márcia R ^c   Casali, Emerson A ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Instituto Porto Alegre da Igreja Metodista   (Brazil)

^c UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

Author keywords

Diabetes; E NPPs; E NTPDases; Ecto 5 nucleotidase CD73

Indexed keywords

ADENOSINE; ADENOSINE TRIPHOSPHATASE; ECTOATPASE; NUCLEOTIDE; STREPTOZOCIN;

ANIMAL; ARTICLE; DIABETES MELLITUS; HYDROLYSIS; MALE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; RAT; SERUM; WISTAR RAT;

ADENOSINE; ADENOSINE TRIPHOSPHATASES; ANIMALS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; HYDROLYSIS; MALE; NUCLEOTIDES; RATS; RATS, WISTAR; SERUM; STREPTOZOCIN;

ANIMALIA; RATTUS;

EID: 77951737378     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.3109/13813451003777067     Document Type: Article

References (48)

1. Ataman OV. (1991). Ectonucleotidase activity of isolated strips of arteries and veins of experimental animals. Influence of various damaging agents on ecto-ATPase activity of blood vessels. Fiziol Zh 37:32-37
2. Atkinson B, Dwyer K, Enjyoji K. (2006). Ecto-nucleotidases of CD39/NTPDase family modulate platelet activation and thrombus formation: Potential as therapeutic targets. Blood Cells Mol Dis 36:217-222
3. Bitzur R, Cohen H, Kamari Y, Shaish A, Harats D. (2009).Triglycerides and HDL cholesterol: stars or second leads in diabetes? Diabetes Care 32:S373-7.
4. Bodoin P, Burnstock G. (2001). Purinergic signaling: ATP release. Neorochem Res 26:959-969
5. Bradford MM. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
6. Burnstock G. (1991). Dual control of local blood flow by purines. Ann NY Acad Sci 603:31-44.
7. Burnstock G. (2006). Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol Rev 58:58-86.
8. Carr ME. (2001). Diabetes mellitus: a hyperguagulable state. J Diabetes Complications 15:44-54.
9. Chan K, Delfert D, Junges KD. (1986). A direct colorimetric assay for Ca+2-ATPase activity. Anal Biochem 157:375-380
10. Duarte JM, Oses JP, Rodrigues RJ, Cunha RA. (2007). Modifications of purinergic signaling in the hippocampus of streptozotocininduced diabetic rats. Neuroscience 149:382-391
11. Dubyak GR, Elmoatassin C. (1993). Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am J Physiol 265:C577-606.
12. Dwyer KM, Robson SC, Nandurkar HH, Cmapbell DJ, Gock H, Murray-Segal LJ, Fisicaro N, Mysore TB, Kaczmarek E, Cowan PJ, d'Apice AJ. (2004). Thromboregulatory manifestations in human CD 39 transgenic mice and the implications for thrombotic disease and transplantation. J Clin Invest 113:1440-1446
13. Erlinge D, Burnstock G. (2008). P2 receptors in cardiovascular regulation and disease. Purinergic Signal 4:1-20.
14. Frasseto SS, Dias RD, Sarkis JJF. (1993). Characterization of an ATP-diphosphohydrolase activity in rat blood platelets. Mol Cell Biochem 129:47-55.
15. Freitas HS, Schaan BD, Seraphim PM, Nunes MT, Machado UF. (2005). Acute and short-term insulin-iduced molecular adaptations of GLUT2 gene expression in the renal cortex of diabetic rats. Mol Cell Endocrinol 237:49-57.
16. Friedman DJ, Rennke HG, Csizmadia E, Enjyoji K, Robson SC. (2007). The vascular ectonucleotidases ENTPD1 is a novel renoprotective factor in diabetic nephropathy. Diabetes 56:2371-2379
17. Furstenau CR, Trentin DS, Gossenheimer AN, Ramos DB, Casali EA, Barreto-Chaves ML, Sarkis JJF. (2008). Ectonucleotidaseactivities are altered in serum and platelets of L-NAMEtreated rats. Blood Cells Mol Dis 41:223-229
18. Graham M, Qureshi A, Noueihed R, Harrison S, Howarth FC. (2004). Effects of halothane, isoflurane, sevoflurane and desflurane on contraction of ventricular myocytes from streptozotocin-induced diabetic rats. Mol Cell Biochem 261:209-215 (Pubitemid 39004533)
19. Hellman B, Dansk H, Grapengiesser E. (2004). Pancratic beta-cells communicate via intermittent release of ATP. Am J Physiol Endocrinol Metab 286: E759-65.
20. Hermans MP. (2007). Diabetes and endothelium. Acta Clin Belg 62:97-101.
21. Howarth FC, Jacobson M, Shafiullah M, Adeghate E. (2005). Longterm effects of streptozotocin-induced diabetes on the electrocardiogram, physical activity and body temperatures in rats. Exp Physiol 90:827-835 (Pubitemid 41659553)
22. Howarth FC, Jacobson M, Shafiullah M, Adeghate E. (2006). Effects of insulin treatment on heart rhythm, body temperature and physical activity in streptozotocin-induced diabetic rat. Clin Exp Pharmacol Physiol 33:327-331
23. Koziak K, Kaczmarek E, Kittel A, Sevigny J, Blusztajn JK, Schulte Am Esch 2nd J, Imai M, Guckelberger O, Goepfert C, Qawi I, Robson SC. (2000). Palmitoylation targets CD39/endothelial ATP diphosphohydrolase to caveolae. J Biol Chem 275:2057-2062
24. Kuzuya T, Nakagawa S, Satoh J, Kanazawa Y, Iwamoto Y, Kobayashi M, Nanjo K, Sasaki A, Seino Y, Ito C, Shima K, Nonaka K, Kadowaki T. (2002). Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res Clin Pract 55:65-85.
25. Liu I-M, Chang CK, Juang S-W, Kou DH, Tong YC, Cheng KC, Cheng JT. (2008). Role of hyperglycaemia in the pathogenesis of hypertension observed in type-1 diabetic rats. Int J Exp Path 89:292-300.
26. Lunkes GI, Lunkes D, Stefanello F, Morsch A, Morsch VM, Mazzanti CM, Schetinger MR. (2003). Enzymes that hydrolyze adenine nucleotides in diabetes and associated pathologies. Thromb Res 109:189-194
27. Lunkes GI, Lunkes DS, Morsch VM, Mazzanti CM, Morsch AL, Miron VR, Schetinger MR. (2004). NTPDase and 5′-nucleotidase activities in rats with alloxan-induced diabetes. Diabetes Res Clin Pract 65:1-16.
28. Lunkes GI, Lunkes DS, Leal D, Araujo Mdo C, Correa M, Becker L, Rosa CS, Morsch VM, Schetinger MR. (2008). Effect of high glucose levels in human platelet NTPDase and 5′-nucleotidase activities. Diabetes Res Clin Pract 81:351-357
29. Mubagwa K, Mullane K, Flemeng W. (1996). Role of adenosine in the heart and circulation. Cardiovasc Res 18:565-574
30. Nilsson J, Nilsson LM, Chen YW. (2006). High glucose activates nuclear factor of activated T cells in native vascular smooth muscle. Arterioscler Thromb Vasc Biol 26:794-800.
31. Oses JP, Cardoso CM, Germano RA, Kirst IB, Rucker B, Furstenau CR, Wink MR, Bonan CD, Battastini AM, Sarkis JJ. (2004). Soluble NTPDase: an additional system of nucleotide hydrolysis in rat blood serum. Life Sci 74:3275-3284
32. Papanikolaou A, Papafotika A, Murphy C, Papamarcaki T, Tsolas O, Drab M, Kurzchalia TV, Kasper M, Christoforidis S. (2005). Cholesterol-dependent lipid assemblies regulate the activity of the ecto-nucleotidase CD39. J Biol Chem 280: 26406-26414
33. Parodi J, Flores C, Aguayo C, Rudolph MI, Casanello P, Sobrevia L. (2002). Inhibition of nitrobenzylthioinosine-sensitive adenosine transport by elevated D-glucose involves activation of P2Y2 purinoceptors in human umbilical vein endothelial cell. Cir Res 90:570-577
34. Pilla C, Emanuelli T, Frasseto SS, Battastini AMO, Dias RD, Sarkis JJF. (1996). ATP diphosphohydrolase activity (apyrase, EC 3.6.1.5) in human blood platelets. Platelets 7: 225-230
35. Pochmann D, Rucker B, Battastini AMO, Sarkis JJ. (2004). Ovariectomy and estradiol replacement therapy alters the adenine nucleotide hysrolysis in rat blood serum. Thromb Res 114:275-281
36. Ralevic V, Burnstock G. (2003). Involvement of purinergic signaling in cardiovascular diseases. Drug News Perspect 16: 133-140
37. Robson S, Sevigny J, Zimmermann H. (2006). The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance. Purinergic Signal 2:409-430
38. Sakovicz M, Pawelczyk T. (2002). Insulin restores expression of adenosine kinase in streptozotocin-induced diabetes mellitus rats. Mol Cel Biochem 236:163-171
39. Sakura H, Nagashima S, Nakashima A, Maeda M. (1998). Characterization of fetal serum 5′-nucleotide phosphodiesterase: a novel function as a platelet aggregation inhibitor in fetal circulation. Thromb Res 91:83-89
40. Takenaka K, Yamagishi S, Matsui T, Nakamura K, Imaizumi T. (2006). Role of advanced glycation end products (AGEs) in thrombogenic abnormalities in diabetes. Curr Neurovasc Res 3:73-77
41. Voelter W, Zech K, Arnold P, Ludwig G. (1980). Determination of selected pyrimidines, purines and their metabolites in serum and uridine by reversad-phase ion-pair chromatography. J Chromatogr 199:345-354
42. Wold LE, Ren J. (2004). Streptozotocin directly impairs cardiac contractile function in isolated ventricular myocytes via a p38 map kinase-dependent oxidative stress mechanism. Biochem Biophys Res Commun 318:1066-1071
43. Yegutkin GG. (1997). Kinetic analysis of enzymatic hydrolysis of ATP in human and rat blood serum. Biochem 62:724-728
44. Yegutkin GG. (2008). Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signaling cascade. Biochim Biophys Acta 1783:673-694
45. Yegutkin GG, Bodin P, Burnstock G. (2000). Effect of shear stress on the release of soluble ecto-enzymes ATPase and 5′-nucleotidase along with endogenous ATP from vascular endothelial cells. Br J Pharmacol 129:921-926
46. Zimmermann H. (1996). Biochemistry, localization and functional roles of ecto-nucleotidases in the nervous system. Prog Neurobiol 49:587-618.
47. Zimmermann H. (1999). Two novel families of ectonucleotidases: molecular structures, catalytic properties and a search for function. Trends Pharmacol Sci 20:231-236
48. Zimmermann H. (2001). Ectonucleotidases: some developments and a note on nomenclature. Drug Develop Res 52:44-56.